FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035265 [Registered on: 29/07/2021] Trial Registered Prospectively
Last Modified On: 28/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Other 
Public Title of Study   SIDDHAR YOGAM AND INJI CHOORANAM FOR KNEE OSTEOARTHRITIS TREATMENT 
Scientific Title of Study   A COMPARATIVE CLINICAL TRIAL OF SIDDHAR YOGAM AND INJI CHOORANAM (INTERNAL) IN THE MANAGEMENT OF AZHAL KEEL VAYU (OSTEOARTHRITIS OF KNEE JOINT) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S DHIVYA BHARATHI 
Designation  PG SCHOLAR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  ROOM NO 3A AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
ROOM NO 3A AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
Kancheepuram
TAMIL NADU
600047
India 
Phone  9677787331  
Fax    
Email  dbidhivya16296@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr V MAHALAKSHMI 
Designation  ASSOCIATE PROFESSOR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  Room no 3, Dept. of Sirappu Maruthuvam, AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
ROOM no 3A, Dept. of Siddhar Yoga Maruthuvam, AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
Kancheepuram
TAMIL NADU
600047
India 
Phone  9940668576  
Fax    
Email  rvmahalakshmi85@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S DHIVYA BHARATHI 
Designation  PG SCHOLAR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  ROOM NO 3A AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
ROOM NO 3A AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA CHENNAI
Kancheepuram
TAMIL NADU
600047
India 
Phone  9677787331  
Fax    
Email  dbidhivya16296@gmail.com  
 
Source of Monetary or Material Support  
AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA 
 
Primary Sponsor  
Name  AYOTHIDOSS PANDITHAR HOSPITAL 
Address  NATIONAL INSTITUTE OF SIDDHA CHENNAI 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S DHIVYA BHARATHI  AYOTHIDOSS PANDITHAR HOSPITAL, National Institute of Siddha  Room no 3A, Dept. of Siddhar Yoga Maruthuvam,
Kancheepuram
TAMIL NADU 
9677787331

dbidhivya16296@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  INJI CHOORANAM  1500mg bid with water for 45 days 
Comparator Agent  SIDDHAR YOGAM  33 - 42 mins, 7 days once for 45 days (7 sittings) 
Intervention  SIDDHAR YOGAM AND INJI CHOORANAM  Inji choornam - 1500mg bid with water for 45 days. Siddhar Yogam - 33 - 42 mins, 7 days once for 45 days (7 sittings) 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  • Age: 30 - 65years
• Sex: male, female and transgender
• Patients having the symptoms of pain, tenderness, stiffness, restricted movements, swelling and crepitation in knee joint.
• Patient willing to give blood sample for laboratory investigation.
• Patient willing to undergo radiological investigation (x-ray knee joint).
• Patient willing to sign the informed consent.
 
 
ExclusionCriteria 
Details  • Psoriatic arthritis
• Rheumatoid arthritis
• Pregnancy and lactation
• Coronary artery diseases
• Diabetes mellitus
• Uncontrolled hypertension
• Recent surgery or trauma
• Patient with any other serious illness
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The outcome of the trial is to access the reduction in the symptoms of knee osteoarthritis by WOMAC Scale (Western Ontario and McMaster Universities Osteoarthritis Index)  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The aim of the study is to evaluate the therapeutic efficacy of Siddhar Yogam and Inji chooranam (internal) in the management of Azhal keel vayu (Osteoarthritis of knee joint). The objective of the study is to study the Siddha basic principles relevant to the disease. The justification of the study is, the selected Yoga postures might focus on flexibility of the joint and increased blood flow in that affected area, presumably by aligning knee joints. Many clinical research studies showed that the selected Yoga postures are effective and safe in the management of Azhal keel vayu (Osteoarthritis). The major ingredient in the formulation Inji chooranam is Inji (Zingiber officinale) is a kayakarpa (Rejuvination) medicine which is effective in the management of old age problems like Osteoarthritis. Most of the other ingredients of Inji chooranam have anti-inflammatory, anti-oxidant, analgesic and anti-arthritic activities. 

90 selected patients will be divided randomly and grouped into 3 groups.

GROUP-A                         : 30 patients with Yogam only

GROUP-B                         : 30 patients with Inji chooranam only.

GROUP-C: 30 patients will be treated with Yogam and Inji chooranam.

Before starting the treatment, purgation will be given with Meganatha kuligai-2 tablets (130 mg) with warm water in empty stomach at early morning for balancing the deranged Uyir thathukal and advised to take rest on next day. The administration of trial drug Inji chooranam (internal) and Yogam therapy will be started continuously for 45 days to the patients according to the group.

Yogam procedures will be taught and advised to practice continuously for 7 days. The enrolled patients should visit the hospital once in 7 days upto 45 days. In each visit, clinical assessment will be done and prognosis will be noted. Laboratory investigations will be done before and after treatment. Radiological investigations will be done before enrolling the Patient into study. After completion of the trial period, the trial patients will be followed for next two months to observe any recurrence of symptoms. The outcome of the trial will be accessed by WOMAC Scale (Western Ontario and McMaster Universities Osteoarthritis Index).

 

 
Close